PDF
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Mid Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Vård & Omsorg |
Continued profit improvement
Summary of the first quarter
· Net revenue was SEK 2,533 million (2,407), an increase of 5 percent.
· Organic growth was -2.1 percent (-1.0).
· Operating profit was SEK 143m (87).
· Adjusted operating profit was SEK 108m (100), an increase of 8 percent.
· Net profit after tax for the period amounted to SEK 74m (21).
· Earnings per share for the period amounted to SEK 1.44 (0.44).
· Cash flow for the period amounted to SEK 108m (-59).
· Operating cash flow amounted to SEK 156m (110).
Highlights
· Adjusted operating profit during the quarter improved by 8 percent.
· The leverage ratio fell to 2.6x.
· Operating cash flow improved to SEK 156m.
· Continued profitable growth in Norway.
· The elderly care business in Finland was divested for a consideration of EUR 25m, corresponding to approx. SEK 285m.
· As of March 31, 2025, 1,267,357 own shares, corresponding to 2.4 percent of the total shares and votes, were repurchased.
Significant events in the first quarter of 2025
· In January 2025, it was announced that Humana had signed up to the Science Based Targets initiative and committed to work towards scientifically based emissions targets.
· In February 2025, 21 elderly care homes in Finland were divested for a consideration of EUR 25m, corresponding to approx. SEK 285m.
· In February and March 2025, the Board decided to exercise the authority granted to it by the 2024 annual general meeting (AGM) to buy back 2,000,000 shares. As of 31 March 2025, the company's total holding of own shares amounted to 1,267,357 shares, which corresponds to 2.4 percent of the total number of shares and votes. After the buyback during the quarter, the total number of shares excluding the company's own holding is 50,558,701.
· In March 2025, Humana announced its intention to strengthen Group executive management by appointing Jonas Jarborn to the role of Quality and Compliance Director.
· In March 2025, Humana announced a further addition to Group executive management with the appointment of Gabriella Reuterswärd as Chief Marketing Officer.
President and CEO Nathalie Boulas Nilsson comments
" The first quarter of the year showed further improvements in the Group's performance, primarily driven by Norway, where synergy effects and growth led to an increase in margins, although an improvement in profitability in Sweden was also a contributory factor. Our diversified portfolio is promoting stability - the rolling 12-month adjusted operating margin has reached at least 5 percent for the third consecutive quarter. This is despite digital infrastructure investments, which will help ensure that the savings programme we have initiated will have an effect later in the year."
Read the full comment in the report.
Conference call
A webcast will be held on 24 April 2025 at 09:00 CET at which President and CEO Nathalie Boulas Nilsson and CFO Christoffer Herou will present the report and answer questions. If you wish to take part via the webcast, use the following link.
If you wish to participate via conference call, please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the conference call.
For more information, please contact:
Christoffer Herou
CFO
+46 72 582 86 16, christoffer.herou@humana.se
Ewelina Pettersson
Head of IR
+46 73 074 79 12, ewelina.pettersson@humana.se
This disclosure contains information that Humana AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 24-04-2025 08:00 CET.